Help | Staff Login
2021 Regular Session
At the request of:
Chief Sponsors:
Regular Sponsors:
Bill Title: Relating to the price of prescription drugs.
Catchline/Summary: Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for nine drugs and at least one insulin product, from among drugs reported to Prescription Drug Price Transparency program by prescription drug manufacturers, drugs reported by insurers in filings and insulin drugs marketed in this state, that are expected to create affordability challenges for health systems or high out-of-pocket costs for patients in Oregon based on specified criteria.
Chapter Number: Chapter 598
Fiscal Impact: Budget Report Issued
Revenue Impact: No Revenue Impact
Measure Analysis: Staff Measure Summary / Impact Statements
Current Location: Chapter Number Assigned
Current Committee:
Current Subcommittee:
Subsequent Referral(s):
Potential Conflicts of Interest/Vote Explanations: Potential Conflicts of Interest/Vote Explanation Documents
Measure History
Scheduled Events